OCTOBER 2023LIFE SCIENCES REVIEW 19he biopharmaceutical industry, a field where innovation and life-altering breakthroughs are the norm, has experienced unprecedented growth and change in recent decades. This thriving landscape has been a hotbed of scientific discovery, technological advancements, and novel therapies that have fundamentally transformed healthcare. Tosoh Bioscience has been leading from the front since the inception of this industry. As pioneers in analytical chromatography and downstream processing (DSP), our commitment to quality, innovation, and collaboration has played a crucial role in shaping the industry's progress. Our legacy is not just one of participation; it is about setting the pace, driving change, and helping the biopharmaceutical community push the frontiers of what is possible in healthcare. Our influence resonates through every facet of the industry, reflecting a dedication that goes beyond the boundaries of a mere supplier and into the very heart of what it means to improve lives through science.Transforming Downstream ProcessingThe biopharmaceutical industry has witnessed significant transformation and innovation in downstream processing (DSP), especially in chromatography. Tosoh Bioscience's innovations in that field have revolutionized the way biological drug molecules are analyzed and purified. By Romain Dabre, Associate Director, Global Product Management, Tosoh Bioscience - Separations & PurificationSHAPING THE FUTURE: TOSOH BIOSCIENCE'S IMPACT ON THE BIOPHARMACEUTICAL LANDSCAPETOn the analytical front, we have continually pushed the boundaries of technology, with the latest development allowing better characterization of biomolecules and Cell and Gene Therapy delivery vectors and payloads by combining innovative UHPLC columns with a revolutionary approach to light scattering.Similarly, we capitalized on our decades of experience in developing innovative process chromatography resins by combining them with targeted investment in innovative instruments and pre-packed column technology to become the first holistic supplier of multicolumn chromatography (MCC) solutions. These advancements haven't merely paralleled the biopharmaceutical industry's progress; they have actively shaped it, making CXO INSIGHTSBy facilitating knowledge sharing and fostering partnerships, we create an ecosystem where cutting-edge solutions can be effectively implemented
< Page 9 | Page 11 >